Price$204.79+3.62 (+1.80%)
01:30 PM07:45 PM
News · 26 weeks45-50%
2025-10-262026-04-19
Mix1690d
- Other5(31%)
- SEC Filings4(25%)
- Insider4(25%)
- M&A1(6%)
- Dividends1(6%)
- Leadership1(6%)
Latest news
25 items- INSIDERSEC Form 4 filed by Hall Patricia Hemingway4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- PRCardinal Health report highlights growing momentum to expand advanced therapies into community care settingsResearch confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes.DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE:CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care. Advanced therapies are innovative gene-, cell- and tissue-based treatments that target the root cause of disease by repairing, replacing or regenerating damaged cells, offering long-term benefits for many conditions. As more therapies shift to outpat
- PRCardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapiesDUBLIN, Ohio, April 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for Theranostics Advancement (CTA) in Indianapolis, Indiana. The addition of a high-capacity production line to its Drug Master File (DMF) will substantially increase Cardinal Health's supply of cGMP-compliant Ac-225 for use in investigational therapeutic drug products and future commercial manufacturing novel therapies. Ac-225 is an alpha-emitting radionuclide that can be linked to molecules l
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Cardinal Health Inc.SCHEDULE 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)
- PRCardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30DUBLIN, Ohio, March 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release third-quarter financial results for its fiscal year 2026 on April 30 as previously indicated, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.About Card
- SECCardinal Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- PRCardinal Health Appoints Patricia A. Hemingway Hall as Board ChairDUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately. Mr. Kenny has served on the Board since 2007 and as Chairman since 2018. During his tenure on the Board, Mr. Kenny supported the Company through periods of significant transformation, including strategic portfolio evolution and operational improvement initiatives."On behalf of the Board and our management team, we are d
- SECCardinal Health Inc. filed SEC Form 8-K: Leadership Update8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- INSIDERChief Information Officer Greene Michelle D. sold $627,387 worth of shares (2,746 units at $228.47), decreasing direct ownership by 18% to 12,230 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- PRCardinal Health report highlights cost savings and provider confidence in biosimilarsNew analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains.DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments. "Since 2015, biosimilars have generated more than $56 billion i
- INSIDERChief Financial Officer Alt Aaron E covered exercise/tax liability with 1,914 shares and sold $524,964 worth of shares (2,328 units at $225.50), decreasing direct ownership by 14% to 26,408 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- PRCardinal Health Board of Directors Approves Quarterly DividendDUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc
- INSIDERDirector Hall Patricia Hemingway sold $918,880 worth of shares (4,000 units at $229.72), decreasing direct ownership by 12% to 28,264 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- SECSEC Form 10-Q filed by Cardinal Health Inc.10-Q - CARDINAL HEALTH INC (0000721371) (Filer)
- SECCardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- PRCardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises OutlookRevenue increased 19% to $65.6 billionGAAP1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35Cardinal Health completes annual baseline share repurchase of $750 millionCardinal Health reaches targeted leverage range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29%
- INSIDERChief Human Resources Officer Pitteroff Valerie Christine was granted 3,982 shares, increasing direct ownership by 99% to 8,022 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- SECCardinal Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- PRCardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference PresentationRaising Fiscal 2026 Outlook: Cardinal Health is increasing expectations for fiscal year 2026 non-GAAP diluted earnings per share (EPS)1 to at least $10.00, from its prior guidance range of $9.65 to $9.85Accelerating Specialty Growth: The company expects that its Specialty revenues will surpass $50 billion in fiscal 2026, marking a 16% compounded annual growth rate (CAGR) over three years2Successfully Navigating IRA Changes: The company confirms the successful transition of its manufacturer distribution service agreements for all branded pharmaceutical products impacted by the 2026 Medicare Drug Price Negotiation ProgramIntroducing ContinuCare™ Pathway: The company's direct-to-patient at-Home
- ANALYSTCardinal Health upgraded by CitigroupCitigroup upgraded Cardinal Health from Neutral to Buy
- INSIDERNew insider Pitteroff Valerie Christine claimed ownership of 4,503 shares (SEC Form 3)3 - CARDINAL HEALTH INC (0000721371) (Issuer)
- PRCardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5DUBLIN, Ohio, Jan. 6, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months. About Cardinal Health Cardinal
- ANALYSTBarclays initiated coverage on Cardinal Health with a new price targetBarclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00
- INSIDERSEC Form 4 filed by Cardinal Health Inc.4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERCEO, PSS Segment Weitzman Deborah covered exercise/tax liability with 551 shares, decreasing direct ownership by 1% to 52,877 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)